Leflunomide

Overview

Leflunomide is an immunomodulatory drug primarily used for the treatment of active moderate to severe rheumatoid arthritis. It works by inhibiting dihydroorotate dehydrogenase, an enzyme involved in pyrimidine synthesis, thus reducing lymphocyte proliferation.

API suppliers (21)

Suppliers of Leflunomide backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Alembic Pharmaceuticals LimitedIndia1 active DMF
• Forest Laboratories, Inc.United States1 active DMF
• Cipla USA, Inc.USA1 active DMF
• Emcure Pharmaceuticals LimitedIndia1 active DMF
• Emcure Pharmaceuticals LimitedIndia1 active DMF
• Cipla USA, Inc.USA1 active DMF
• Alembic Pharmaceuticals LimitedIndia1 active DMF
• Forest Laboratories, Inc.United States1 active DMF
• EUROAPI GERMANY GMBHGermany1 active DMF
• EUROAPI GERMANY GMBHGermany1 active DMF
• Emcure Pharmaceuticals LimitedIndia1 active DMF
• Cipla USA, Inc.USA1 active DMF
• Alembic Pharmaceuticals LimitedIndia1 active DMF
• Forest Laboratories, Inc.United States1 active DMF
• Forest Laboratories, Inc.United States1 active DMF
• Cipla USA, Inc.USA1 active DMF
• Alembic Pharmaceuticals LimitedIndia1 active DMF
• Emcure Pharmaceuticals LimitedIndia1 active DMF
• EUROAPI GERMANY GMBHGermany1 active DMF
• MAPRIMED SA1 active DMF
• Unichem Laboratories Ltd.India

Therapeutic areas